特发性肺纤维化中独特壁细胞和成纤维细胞促进致病性浆细胞积聚
该研究利用空间转录组学等技术,发现IPF肺纤维化区域广泛分布浆细胞和局部抗体,并从三级淋巴结构播散。独特的壁细胞通过CCR7配体招募T细胞促进浆细胞生成,IPF相关成纤维细胞分泌CXCL12为浆细胞提供髓外生态位。中和CCR7配体或CXCL12可减少博来霉素小鼠肺内浆细胞和局部抗体积聚,降低TGF-β浓度并减轻肺纤维化。
要点
- IPF肺纤维化区域广泛分布浆细胞和局部抗体,起源于三级淋巴结构。
- 壁细胞表达CCR7配体招募T细胞,成纤维细胞分泌CXCL12促进浆细胞积聚。
- 中和CCR7配体或CXCL12可减轻博来霉素小鼠肺纤维化。
核心结论
- IPF肺纤维化区域广泛分布浆细胞和局部抗体,独特壁细胞和成纤维细胞亚群促进病理性浆细胞和抗体积聚。
研究设计与样本
- 使用IPF患者和对照正常肺的外植体组织进行空间转录组检测,并验证RNAscope和免疫荧光。
- 检测IPF和对照肺来源成纤维细胞吸引浆细胞的能力。
- 在博来霉素处理小鼠中给予中和抗体研究影响肺浆细胞积聚和纤维化的分子。
主要发现
- 人IPF肺纤维化区域浆细胞和局部抗体分布广泛,从产生浆细胞的三级淋巴结构播散。
- 新型壁细胞包裹三级淋巴结构区域血管,表达CCR7配体吸引T细胞进入三级淋巴结构促进浆细胞生成。
- 独特IPF相关成纤维细胞分泌CXCL12,提供髓外生态位促进浆细胞在纤维化区域播散和积聚。
- 中和CCR7配体或CXCL12减少博来霉素小鼠肺内浆细胞和局部抗体积聚,降低TGF-β浓度并减轻肺纤维化。
临床怎么用
- 靶向CCR7配体或CXCL12通路可能减少IPF肺内病理性浆细胞和抗体积聚,减轻纤维化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is characterised by significant but poorly understood immune and antibody responses. This study examines the spatial transcriptomes and microenvironmental niches of antibody-producing plasma cells and tertiary lymphoid structures in IPF lungs, and the molecular pathways influencing antibody accumulation and pulmonary fibrosis. METHODS: Explant lung tissues from IPF patients and control normal lungs were used for spatial transcriptome assays and validating RNAscope and immunofluorescence assays. Fibroblasts derived from IPF and control lungs were examined for their ability to attract plasma cells. Neutralising antibodies were administered to investigate molecules affecting pulmonary plasma cell accumulation and fibrosis in bleomycin-treated mice. RESULTS: Human IPF lungs exhibited a remarkably widespread distribution of plasma cells and local antibodies in the fibrotic regions, disseminating from plasma cell-generating tertiary lymphoid structures. Novel mural cells wrapped the vessels in tertiary lymphoid structure regions, expressing C-C motif chemokine receptor 7 (CCR7) ligands that attracted T-cells into tertiary lymphoid structures to promote plasma cell generation. Distinct IPF-associated fibroblasts further secreted C-X-C motif chemokine ligand 12 (CXCL12), providing an extramedullary niche to foster the dissemination and accumulation of plasma cells in the fibrotic regions. Neutralisation of CCR7 ligands or CXCL12 reduced plasma cell and local antibody accumulation in the lungs of bleomycin-treated mice, leading to reduced transforming growth factor β concentrations and alleviated pulmonary fibrosis. CONCLUSIONS: Plasma cells and local antibodies are widely distributed in the fibrotic regions of IPF lungs. Distinct subsets of IPF-associated mural cells and fibroblasts promote pathological plasma cell and antibody accumulation. These findings have potential implications for strategies aimed at targeting immune and antibody responses to combat IPF.
引用
- Yang Z, Cao G, Tan X, et al. Distinct mural cells and fibroblasts promote pathogenic plasma cell accumulation in idiopathic pulmonary fibrosis. Eur Respir J. 2025. PMID: 39978854. doi:10.1183/13993003.01114-2024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。